People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Quinnova Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $19.7M | $68.0M | 2009 |
James Thomas Datin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Thomas Datin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James A. Datin | 1 | 6 |
| Brian M Gallagher | 1 | 3 |
| Aaron A. Davidson | 1 | 2 |
| G. Frits Besselaar | 1 | 1 |
| Alex M. Zisson | 1 | 1 |
| Jeffrey S. Day | 1 | 1 |
| Duane J. Napolitana | 1 | 1 |
| Al Thomas Altomari | 1 | 1 |
| Lincoln Thomas Krochmal | 1 | 1 |
| Aaron Frits Davidson | 1 | 1 |
| Alex Frits Zisson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.